Where can I find news about MSGR?

Press releases, SEC filings, and prospectus updates from the fund issuer are listed on this page. Direxion mRNA ETF (MSGR) news is sourced from regulatory filings and the issuer's investor relations feed.

How can I track MSGR's SEC filings?

MSGR's 485APOS / 485BPOS prospectus filings, N-CSR shareholder reports, and other regulatory filings are listed on this page with direct links to the SEC EDGAR copies. Filings update as the issuer submits them — typically semi-annually for shareholder reports.

Where can I find MSGR's prospectus?

Direxion mRNA ETF (MSGR)'s most recent prospectus is linked in the filings section on this page. Issuers publish the full prospectus on their product page and re-file it annually with material updates flagged in the 485BPOS amendment.

MSGR (Direxion mRNA ETF) is no longer actively trading.

This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

MSGR

Direxion mRNA ETF

AMEX·Asset Management · Financial Services

$13.91$0.10+0.73%

Apr 21 2:41 PM UTC

News & Analysis

Best-Performing ETFs of Last Week
Wall Street was downbeat last week. The S&P 500 (down 2.1%), the Dow Jones (down 1.7%), the Nasdaq Composite (down 2.7%) and the Russell 2000 (down 1.9%) -- all lost last week.
zacks.comDec 20, 2022 · 9:02 AM
Biotech & Crypto -- Best ETF Areas of Last Week
Biotech and cryptocurrency -- two ETF areas outperformed last week.
zacks.comAug 8, 2022 · 3:48 PM
China ETFs Drop On Audit Enforcement
The first tranche of Chinese ADRs affected by a 2020 law has been released.
etf.comMar 11, 2022 · 3:03 PM
Direxion Launches mRNA Technology-Focused ETF
Direxion has announced today in a press release the launch of their newest ETF that focuses on the applications and developments of messenger RNA technology, the Direxion mRNA ETF (MSGR). The fund looks to capture the growth within the mRNA field by investing in companies that are working to develop and apply mRNA technology.
etftrends.comDec 9, 2021 · 11:29 AM

Fund Documents

Summary Prospectus497K
Aug 6, 2026View
Prospectus485BPOS
Aug 10, 2026View
Semi-Annual ReportN-CSRS
Jul 8, 2026View
Portfolio HoldingsNPORT-P
Jun 29, 2026View

View all filings on SEC EDGAR

Frequently Asked Questions About MSGR

Where can I find news about MSGR?: Press releases, SEC filings, and prospectus updates from the fund issuer are listed on this page. Direxion mRNA ETF (MSGR) news is sourced from regulatory filings and the issuer's investor relations feed.
How can I track MSGR's SEC filings?: MSGR's 485APOS / 485BPOS prospectus filings, N-CSR shareholder reports, and other regulatory filings are listed on this page with direct links to the SEC EDGAR copies. Filings update as the issuer submits them — typically semi-annually for shareholder reports.
Where can I find MSGR's prospectus?: Direxion mRNA ETF (MSGR)'s most recent prospectus is linked in the filings section on this page. Issuers publish the full prospectus on their product page and re-file it annually with material updates flagged in the 485BPOS amendment.

Direxion mRNA ETF

Frequently Asked Questions About MSGR

Direxion mRNA ETF

Best-Performing ETFs of Last Week

Biotech & Crypto -- Best ETF Areas of Last Week

China ETFs Drop On Audit Enforcement

Direxion Launches mRNA Technology-Focused ETF

Frequently Asked Questions About MSGR

Best-Performing ETFs of Last Week

Biotech & Crypto -- Best ETF Areas of Last Week

China ETFs Drop On Audit Enforcement

Direxion Launches mRNA Technology-Focused ETF